← Back
Data updated: Mar 10, 2026
VIOKACE
Pharmaceuticals
VIOKACE is a biotechnology company with 1 FDA-approved products.
2012
Since
1
Drugs
-
Trials
0
Approved (2yr)
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2012-03-01
- Latest
- 2024-02-28
- Applications
- 1